Effects of Combined Opioids on Pain and Mood in MammalsReport as inadecuate

Effects of Combined Opioids on Pain and Mood in Mammals - Download this document for free, or read online. Document in PDF available to download.

Pain Research and TreatmentVolume 2012 2012, Article ID 145965, 11 pages

Review Article

Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48864, USA

Department of Biomedical Sciences, College of Osteopathic Medicine, University of New England, 11 Hills Beach Road, Biddeford, ME 04005, USA

Department of Environmental Quality, State of Michigan, Lansing, MI 48909-7773, USA

Received 23 August 2011; Accepted 2 January 2012

Academic Editor: Young-Chang P. Arai

Copyright © 2012 Richard H. Rech et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The authors review the opioid literature for evidence of increased analgesia and reduced adverse side effects by combining mu-opioid-receptor MOR agonists, kappa-opioid-receptor KOR agonists , and nonselective low-dose-opioid antagonists LD-Ant. We tested fentanyl MOR agonist and spiradoline KOR agonist, singly and combined, against somatic and visceral pain models. Combined agonists induced additive analgesia in somatic pain and synergistic analgesia in visceral pain. Other investigators report similar effects and reduced tolerance and dependence with combined MOR agonist and KOR agonist. LD-Ant added to either a MOR agonist or KOR agonist markedly enhanced analgesia of either agonist. In accordance with other place-conditioning PC studies, our PC investigations showed fentanyl-induced place preference CPP and spiradoline-induced place aversion CPA. We reduced fentanyl CPP with a low dose of spiradoline and reduced spiradoline CPA with a low dose of fentanyl. We propose combined MOR agonist, KOR agonist, and LD-Ant to produce superior analgesia with reduced adverse side effects, particularly for visceral pain.

Author: Richard H. Rech, David J. Mokler, and Shannon L. Briggs

Source: https://www.hindawi.com/


Related documents